Leigh syndrome

Changed by Ayush Goel, 28 Nov 2014

Updates to Article Attributes

Body was changed:

Leigh disease,also known as subacute necrotizing encephalomyelopathy (SNEM), is a progressive neurodegenerative disorder and invariably leads to death in childhood.

Demographics and clinical presentation

Typically, symptoms become evident before the age of 2, with presentation in later childhood (juvenile form) or adulthood (adult form) being uncommon. Symptoms include 6:

  • psychomotor delay / regression/regression
  • superimposed signs of basal ganglia and brain stem dysfunction
    • ataxia
    • ophthalmoplegia
    • dystonia 
    • respiratory rhythm disturbance
    • cranial nerve palsies
Genetics

The inheritance pattern may be either autosomal recessive or X linked.

Pathology

Leigh disease is one of many mitochondrial disorders, due to a wide variety of genetic mutations in mitochondrial DNA (mtDNA). As such it is only inherited from the mother, as is the case with other mitochondrial disorders.  Some mutations (e.g. SURF 1) are particularly devastating 1

Chronic energy deprivation leads to histological features such as 3:

These findings are similar to those seen in infarction 4.

Markers
  • CSF lactate may be elevated

Radiographic features

CT

CT demonstrates regions of low density matching areas of abnormal T2 signal on MRI (see below) 5. Occasionally some of these areas can demonstrate contrast enhancement 5.

MRI

The distribution tends to be generally symmetrical. 

  • T1:- usually usually demonstrates reduced signal in T2 abnormal areas, although some areas of hyperintensity can be seen, as can some enhancement. 
  • DWI:- in in the acute setting some restricted diffusion may be evident.
  • MR spectroscopy: - features features include
    • elevated choline
    • occasionally elevated lactate
    • reduced NAA

Treatment and prognosis

Prognosis is poor, with death usually occurring in childhood. The later the onset the slower the deterioration. Death is most frequently due to respiratory failure 6.

EtymologyHistory and etymology

It is named after Archibald Denis Leigh (Britith Neuropathologist) who first described the condition in 1951 2.

Differential diagnosis

  • -<li>psychomotor delay / regression</li>
  • +<li>psychomotor delay/regression</li>
  • -</ul><p>These findings are similar to those seen in infarction <sup>4</sup>.</p><h5>Markers</h5><ul><li>CSF lactate may be elevated</li></ul><p> </p><h4>Radiographic features</h4><h5>CT</h5><p>CT demonstrates regions of low density matching areas of abnormal T2 signal on MRI (see below) <sup>5</sup>. Occasionally some of these areas can demonstrate contrast enhancement <sup>5</sup>.</p><h5>MRI</h5><p>The distribution tends to be generally symmetrical. </p><ul>
  • +</ul><p>These findings are similar to those seen in infarction <sup>4</sup>.</p><h5>Markers</h5><ul><li>CSF lactate may be elevated</li></ul><h4>Radiographic features</h4><h5>CT</h5><p>CT demonstrates regions of low density matching areas of abnormal T2 signal on MRI (see below) <sup>5</sup>. Occasionally some of these areas can demonstrate contrast enhancement <sup>5</sup>.</p><h5>MRI</h5><p>The distribution tends to be generally symmetrical. </p><ul>
  • -<strong>T2</strong> - characterised by high signal typically in <sup>3</sup>: <ul>
  • +<strong>T2:</strong> characterised by high signal typically in <sup>3</sup>: <ul>
  • -<li><a href="/articles/periaqueductal-gray-matter">periaqueductal gray matter</a></li>
  • +<li>periaqueductal gray matter</li>
  • -<a href="/articles/putamen">putamen </a>: characteristic but not always present <sup>6</sup>
  • +<a href="/articles/putamen">putamen</a>: characteristic but not always present <sup>6</sup>
  • -<li>remainder of the <a href="/articles/corpus-striatum">corpus striatum</a> (<a href="/articles/globus-pallidus">globus pallidus</a> and <a href="/articles/caudate-nucleus">caudate nucleus</a> (heads) )</li>
  • +<li>remainder of the <a href="/articles/corpus-striatum">corpus striatum</a> [<a href="/articles/globus-pallidus">globus pallidus</a> and <a href="/articles/caudate-nucleus">caudate nucleus</a> (heads)]</li>
  • -<strong>T1 </strong>- usually demonstrates reduced signal in T2 abnormal areas, although some areas of hyperintensity can be seen, as can some enhancement. </li>
  • +<strong>T1:</strong> usually demonstrates reduced signal in T2 abnormal areas, although some areas of hyperintensity can be seen, as can some enhancement. </li>
  • -<strong>DWI </strong>- in the acute setting some restricted diffusion may be evident.</li>
  • +<strong>DWI:</strong> in the acute setting some restricted diffusion may be evident.</li>
  • -<strong>MR spectroscopy</strong> - features include<ul>
  • +<strong>MR spectroscopy:</strong> features include<ul>
  • -</ul><p> </p><h4>Treatment and prognosis</h4><p>Prognosis is poor, with death usually occurring in childhood. The later the onset the slower the deterioration. Death is most frequently due to respiratory failure <sup>6</sup>.</p><h4><strong>Etymology</strong></h4><p>It is named after <strong>Archibald Denis</strong> <strong>Leigh</strong> (Britith Neuropathologist) who first described the condition in 1951 <sup>2</sup>.</p><h4>Differential diagnosis</h4><ul>
  • +</ul><h4>Treatment and prognosis</h4><p>Prognosis is poor, with death usually occurring in childhood. The later the onset the slower the deterioration. Death is most frequently due to respiratory failure <sup>6</sup>.</p><h4><strong>History and etymology</strong></h4><p>It is named after <strong>Archibald Denis</strong> <strong>Leigh</strong> (Britith Neuropathologist) who first described the condition in 1951 <sup>2</sup>.</p><h4>Differential diagnosis</h4><ul>
Images Changes:

Image 1 MRI (T2) ( update )

Caption was changed:
Case 1 -: T2

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.